Publications
- S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity2020 | First Faculty of Medicine
- An update on biomarkers in axial spondyloarthritis2016 | First Faculty of Medicine
- Využití inhibice interleukinu-6 v léčbě obrovskobuněčné arteriitidy2023 | First Faculty of Medicine
- Safety of filgotinib tratment2023 | First Faculty of Medicine
- Certolizumab pegol ve vztahu k akutní přední uveitidě. Výsledky studie C-VIEW2023 | First Faculty of Medicine
- What's new in rheumatology2023 | First Faculty of Medicine
- Takayasuova arteriitida u pacientky s axiální spondyloartritidou: nežádoucí účinek léčby, nebo kombinace dvou chorob?2023 | First Faculty of Medicine
- Long-term outcomes of ixekizumab treatment in patients with axial spondyloarthritis2023 | First Faculty of Medicine
- Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects2022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
Loading network view...